|
|
|
Insider
Information: |
Coughlin Christopher J |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
342,599 |
|
Indirect Shares
|
17,342 |
|
|
Direct
Value |
$12,691,850 |
|
|
Indirect Value
|
$3,201,289 |
|
|
Total
Shares |
359,941 |
|
|
Total
Value |
$15,893,139 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-5.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Interpublic Group of Companies |
IPG |
CFO and COO, Director |
2004-05-18 |
81,842 |
2004-05-18 |
0 |
Premium* |
|
Dun & Bradstreet Corp |
DNB |
Director |
2017-03-10 |
16,535 |
2017-03-10 |
800 |
Premium* |
|
Johnson Controls International plc |
JCI |
EVP and CFO |
2010-11-26 |
88,558 |
2005-03-07 |
0 |
Premium* |
|
Covidien Plc |
COV |
Director |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
Plx Pharma Inc |
PLXP |
Director |
2014-03-18 |
109,309 |
|
0 |
Premium* |
|
Allergan plc |
AGN |
Director |
2020-05-08 |
0 |
2020-05-08 |
16,542 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2014-07-22 |
0 |
Premium* |
|
Hologic Inc |
HOLX |
Director |
2017-03-08 |
7,633 |
|
0 |
Premium* |
|
Prestige Brands Holdings Inc |
PBH |
Director |
2022-08-02 |
13,218 |
2019-07-30 |
0 |
Premium* |
|
Centene Corp |
CNC |
Director |
2024-05-14 |
25,504 |
2022-02-07 |
0 |
Premium* |
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
180 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNB |
Dun & Bradstreet Corp |
Director |
|
2013-11-12 |
4 |
S |
$110.75 |
$478,335 |
D/D |
(4,319) |
12,543 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2015-11-06 |
4 |
S |
$112.50 |
$262,134 |
D/D |
(2,330) |
15,057 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2017-12-05 |
4 |
A |
$112.75 |
$1,127,500 |
D/D |
10,000 |
16,333 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2014-12-12 |
4 |
A |
$114.86 |
$5,914 |
D/D |
51 |
13,938 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2013-12-13 |
4 |
A |
$116.06 |
$4,839 |
D/D |
42 |
12,584 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2014-09-12 |
4 |
A |
$117.05 |
$5,892 |
D/D |
50 |
13,887 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2017-06-15 |
4 |
B |
$117.10 |
$234,200 |
D/D |
2,000 |
6,333 |
2.39 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2018-04-30 |
4 |
B |
$120.79 |
$1,207,900 |
D/D |
10,000 |
26,333 |
2.39 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2016-12-09 |
4 |
A |
$122.96 |
$7,698 |
D/D |
63 |
16,461 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2016-06-10 |
4 |
A |
$126.04 |
$7,641 |
D/D |
61 |
16,342 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2015-03-11 |
4 |
A |
$127.21 |
$6,241 |
D/D |
49 |
13,987 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2015-06-12 |
4 |
A |
$129.73 |
$6,705 |
D/D |
52 |
14,993 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2016-09-09 |
4 |
A |
$134.56 |
$7,670 |
D/D |
57 |
16,399 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2019-05-02 |
4 |
A |
$145.33 |
$299,961 |
D/D |
2,064 |
17,080 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2019-04-30 |
4 |
D |
$147.00 |
$140,091 |
D/D |
(953) |
15,016 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2018-05-02 |
4 |
A |
$151.07 |
$299,874 |
D/D |
1,985 |
6,431 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2017-12-05 |
4 |
B |
$163.30 |
$1,633,000 |
D/D |
10,000 |
14,446 |
2.39 |
- |
|
AGN |
Allergan plc |
Director |
|
2020-05-01 |
4 |
D |
$189.74 |
$188,032 |
D/D |
(991) |
16,542 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2018-09-06 |
4 |
B |
$190.55 |
$1,906,394 |
D/D |
10,000 |
16,431 |
2.39 |
- |
|
AGN |
Allergan plc |
Director |
|
2016-05-05 |
4 |
A |
$210.34 |
$249,884 |
D/D |
1,188 |
3,790 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2014-10-30 |
4 |
A |
$243.21 |
$168,788 |
D/D |
694 |
18,261 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2017-05-03 |
4 |
D |
$243.76 |
$162,832 |
D/D |
(668) |
3,223 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2017-05-04 |
4 |
A |
$245.25 |
$299,941 |
D/D |
1,223 |
4,446 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2016-08-08 |
4 |
A |
$248.31 |
$49,910 |
D/D |
201 |
3,991 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2016-08-15 |
4 |
D |
$254.05 |
$25,405 |
D/D |
(100) |
3,891 |
0 |
- |
|
180 Records found
|
|
Page 7 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|